[HTML][HTML] Pharmacological, neural, and psychological mechanisms underlying psychedelics: a critical review

M van Elk, DB Yaden - Neuroscience & Biobehavioral Reviews, 2022 - Elsevier
This paper provides a critical review of several possible mechanisms at different levels of
analysis underlying the effects and therapeutic potential of psychedelics. At the (1) …

Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

A Bahji, GH Vazquez, CA Zarate Jr - Journal of affective disorders, 2021 - Elsevier
Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of …

Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial

AK Davis, FS Barrett, DG May, MP Cosimano… - JAMA …, 2021 - jamanetwork.com
Importance Major depressive disorder (MDD) is a substantial public health burden, but
current treatments have limited effectiveness and adherence. Recent evidence suggests that …

Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology

RA Swarm, JA Paice, DL Anghelescu, M Are… - Journal of the National …, 2019 - jnccn.org
In recent years, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for
Adult Cancer Pain have undergone substantial revisions focusing on the appropriate and …

A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009–January 2019

WS Marcantoni, BS Akoumba, M Wassef… - Journal of affective …, 2020 - Elsevier
Background Sub-anaesthetic administration of ketamine is an emerging practice in patients
presenting treatment resistant depression (TRD), however several outstanding questions …

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3 …

SH Kennedy, RW Lam, RS McIntyre… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …

Reviewing the potential of psychedelics for the treatment of PTSD

E Krediet, T Bostoen, J Breeksema… - International Journal …, 2020 - academic.oup.com
There are few medications with demonstrated efficacy for the treatment of posttraumatic
stress disorder (PTSD). Treatment guidelines have unequivocally designated psychotherapy …

Suicide and suicidal behaviour

G Turecki, DA Brent - The Lancet, 2016 - thelancet.com
Suicide is a complex public health problem of global importance. Suicidal behaviour differs
between sexes, age groups, geographic regions, and sociopolitical settings, and variably …

Ketamine and depression: a narrative review

A Corriger, G Pickering - Drug design, development and therapy, 2019 - Taylor & Francis
Depression is the third leading cause of disability in the world. Depressive symptoms may
be reduced within several weeks after the start of conventional antidepressants, but …

The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis

RS McIntyre, IP Carvalho, LMW Lui, A Majeed… - Journal of affective …, 2020 - Elsevier
Background Ketamine is established as a rapid and effective treatment in adults with
treatment-resistant depression (TRD). The availability of different formulations and routes of …